GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GLI3 | hg38_v1_chr7_-_42152396_42152440, hg38_v1_chr7_-_42152444_42152458, hg38_v1_chr7_-_42237187_42237216 | 0.68 | 6.0e-31 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr9_-_95317671 Show fit | 46.31 |
ENST00000490972.7
ENST00000647778.1 ENST00000649611.1 ENST00000289081.8 |
FA complementation group C |
|
chr22_-_19524400 Show fit | 38.79 |
ENST00000618236.2
|
claudin 5 |
|
chr8_-_27605271 Show fit | 35.01 |
ENST00000522098.1
|
clusterin |
|
chr5_-_42825884 Show fit | 33.72 |
ENST00000506577.5
|
selenoprotein P |
|
chr8_-_27611325 Show fit | 33.57 |
ENST00000523500.5
|
clusterin |
|
chr19_+_44914702 Show fit | 32.81 |
ENST00000592885.5
ENST00000589781.1 |
apolipoprotein C1 |
|
chr19_-_20661563 Show fit | 31.11 |
ENST00000601440.6
ENST00000291750.6 ENST00000595094.1 |
zinc finger protein 626 novel transcript |
|
chr19_-_20661507 Show fit | 30.38 |
ENST00000612591.4
ENST00000595405.1 |
zinc finger protein 626 |
|
chr19_+_44914588 Show fit | 28.69 |
ENST00000592535.6
|
apolipoprotein C1 |
|
chr12_+_78864768 Show fit | 28.43 |
ENST00000261205.9
ENST00000457153.6 |
synaptotagmin 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 109.5 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
25.7 | 102.9 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
18.1 | 90.7 | GO:1902998 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
1.3 | 76.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
1.5 | 72.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
2.5 | 69.0 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
10.0 | 60.1 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
7.9 | 55.1 | GO:0070560 | protein secretion by platelet(GO:0070560) |
6.8 | 47.9 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
2.5 | 43.0 | GO:0007021 | tubulin complex assembly(GO:0007021) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 126.3 | GO:0005615 | extracellular space(GO:0005615) |
6.9 | 111.0 | GO:0042583 | chromaffin granule(GO:0042583) |
4.1 | 102.8 | GO:0042627 | chylomicron(GO:0042627) |
1.3 | 89.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
2.9 | 71.3 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
4.4 | 70.0 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.2 | 53.3 | GO:0001726 | ruffle(GO:0001726) |
1.5 | 47.9 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 45.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
3.7 | 44.4 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.4 | 102.8 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
3.9 | 90.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.1 | 66.7 | GO:0030507 | spectrin binding(GO:0030507) |
2.1 | 62.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
10.0 | 60.1 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.5 | 59.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
2.8 | 56.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
4.3 | 55.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 51.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
7.7 | 38.3 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 110.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.1 | 54.7 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 40.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.7 | 38.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.2 | 36.9 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.5 | 35.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.7 | 30.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.3 | 29.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.6 | 27.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.6 | 27.0 | PID RAS PATHWAY | Regulation of Ras family activation |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 70.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
2.7 | 67.4 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.3 | 66.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
1.4 | 62.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 53.9 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
1.3 | 52.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 45.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.2 | 43.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.3 | 35.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
1.3 | 35.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |